What Are the Challenges in Developing Dendritic Cell Vaccines?
Despite their promise, several challenges complicate the development and widespread use of dendritic cell vaccines. These include the complexity of manufacturing personalized vaccines, the need for identifying the right cancer antigens, and the variable immune responses among patients. Additionally, the tumor microenvironment can sometimes suppress the immune response, making it harder for the vaccine to be effective.
